CIK 0001433607 · Non-accelerated filer<br>Smaller reporting company
InspireMD, Inc.
Sign in to watch- Ticker
- NSPR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262123838
- Phone
- (888) 776-6804
- Business address
- 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI, FL, 33126
- Former names
- Saguaro Resources, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-30 | Stuka Paul Director | Purchase | +20,661 | $2.42 | $50K | 444,195 |
| 2025-07-11 | Kester Thomas J Director | Option exercise | +30,624 | $1.38 | $42K | 389,767 |
| 2025-07-11 | Kester Thomas J Director | Option exercise · Series I Warrant (right to buy) | −30,624 | 0 | ||
| 2025-07-01 | Stuka Paul Director | Option exercise | +87,500 | $1.38 | $121K | 423,534 |
| 2025-07-01 | Stuka Paul Director | Option exercise · Series I Warrant (right to buy) | −87,500 | 0 | ||
| 2025-06-29 | BERMAN MICHAEL Director | Option exercise | +61,248 | $1.38 | $85K | 244,994 |
| 2025-06-29 | BERMAN MICHAEL Director | Option exercise · Series I Warrant (right to buy) | −61,248 | 0 | ||
| 2025-06-25 | ROUBIN GARY S Director | Option exercise | +30,624 | $1.38 | $42K | 567,103 |
| 2025-06-25 | ROUBIN GARY S Director | Option exercise · Series I Warrant (right to buy) | −30,624 | 0 | ||
| 2025-05-30 | Gleason Shane Thomas Chief Commercial Officer | Sale | −7,186 | $2.51 | $18K | 1,079,601 |
| 2025-05-29 | Gleason Shane Thomas Chief Commercial Officer | Sale | −3,760 | $2.51 | $9K | 1,086,787 |
| 2025-05-27 | Gleason Shane Thomas Chief Commercial Officer | Sale | −1,572 | $2.51 | $4K | 1,090,547 |
| 2025-05-23 | Gleason Shane Thomas Chief Commercial Officer | Sale | −2,482 | $2.51 | $6K | 1,092,119 |
| 2025-02-25 | Gleason Shane Thomas Chief Commercial Officer | Sale | −10,000 | $3.65 | $37K | 1,094,601 |
| 2025-02-04 | Gleason Shane Thomas Chief Commercial Officer | Sale | −5,132 | $2.46 | $13K | 1,104,601 |
| 2025-02-03 | Gleason Shane Thomas Chief Commercial Officer | Sale | −7,073 | $2.51 | $18K | 1,109,733 |
| 2025-01-31 | Gleason Shane Thomas Chief Commercial Officer | Sale | −9,923 | $2.55 | $25K | 1,116,806 |
| 2025-01-30 | Gleason Shane Thomas Chief Commercial Officer | Sale | −2,454 | $2.51 | $6K | 1,126,729 |
| 2025-01-29 | Gleason Shane Thomas Chief Commercial Officer | Sale | −3,660 | $2.46 | $9K | 1,129,183 |
| 2025-01-28 | Gleason Shane Thomas Chief Commercial Officer | Sale | −2,476 | $2.61 | $6K | 1,132,843 |
Page 4 of 10 · 195 trades